Results 251 to 260 of about 34,281,837 (318)
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck +12 more
wiley +1 more source
Strength through diversity: how cancers thrive when clones cooperate
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
The Vulnerability of Chinese Theaceae Species Under Future Climate Change. [PDF]
Zhao X +9 more
europepmc +1 more source
Why climate action is an opportunity multiplier for mental health. [PDF]
Lawrance EL.
europepmc +1 more source
Event Knowledge Modulates Real-Time Mental Representations of Object State-Change. [PDF]
Lee SH, Kaiser E.
europepmc +1 more source
Behaviour Change for Physical Activity Is Feasible and Effective in Women Living with Metastatic Breast Cancer: A Pilot Two-Arm Randomised Trial. [PDF]
Liu M +4 more
europepmc +1 more source
Missing tissue, missing data: Resolving brain volume loss caused by anti-amyloid therapies. [PDF]
Alves F, Ayton S.
europepmc +1 more source
Efficacy and safety of vemircopan as monotherapy in patients with paroxysmal nocturnal hemoglobinuria. [PDF]
Kulasekararaj A +13 more
europepmc +1 more source

